Literature DB >> 17488767

Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography.

Osama I I Soliman1, Paul Knaapen, Marcel L Geleijnse, Pieter A Dijkmans, Ashraf M Anwar, Attila Nemes, Michelle Michels, Wim B Vletter, Adriaan A Lammertsma, Folkert J ten Cate.   

Abstract

OBJECTIVES: To assess mechanisms of myocardial perfusion impairment in patients with hypertrophic cardiomyopathy (HCM).
METHODS: Fourteen patients with obstructive HCM (mean (SD) age 53 (10) years, 11 men) underwent intravenous adenosine myocardial contrast echocardiography (MCE), positron emission tomography (PET) and cardiac catheterisation. Fourteen healthy volunteers (mean age 31 (4) years, 11 men) served as controls. Relative myocardial blood volume (rBV), exchange flow velocity (beta), myocardial blood flow (MBF), MBF reserve (MFR) and endocardial-to-subepicardial (endo-to-epi) MBF ratio were measured from the steady state and contrast replenishment time-intensity curves.
RESULTS: Patients with HCM had lower rest MBF (for LVRPP-corrected)--mean (SD) (0.92 (0.12) vs 1.13 (0.25) ml/min/g, p<0.01)--and hyperaemic MBF--(2.56 (0.49) vs 4.34 (0.78) ml/min/g, p<0.01) than controls. Resting rBV was lower in patients with HCM (0.094 (0.016) vs 0.138 (0.014) ml/ml), and during hyperaemia (0.104 (0.018) ml/ml vs 0.185 (0.024) ml/ml) (all p<0.001) than in controls. beta tended to be higher in HCM at rest (9.4 (4.6) vs 7.7 (4.2) ml/min) and during hyperaemia (25.8 (6.4) vs 23.1 (6.2) ml/min) than in controls. Septal endo-to-epi MBF decreased during hyperaemia (0.86 (0.15) to 0.64 (0.18), p<0.01). rBV was inversely correlated with left ventricular (LV) mass index (p<0.05). Both hyperaemic and endo-to-epi MBF were inversely correlated with LV end-diastolic pressure, LV mass index, and LV outflow tract pressure gradient (all p<0.05). MCE-derived MBF correlated well with PET at rest (r = 0.84) and hyperaemia (r = 0.87) (all p<0.001).
CONCLUSIONS: In patients with HCM, LV end-diastolic pressure, LV outflow tract pressure gradient, and LV mass index are independent predictors of rBV and hyperaemic MBF.

Entities:  

Mesh:

Year:  2007        PMID: 17488767      PMCID: PMC2000941          DOI: 10.1136/hrt.2006.110460

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  39 in total

1.  Quantification of myocardial perfusion using intravenous myocardial contrast echocardiography in healthy volunteers: comparison with positron emission tomography.

Authors:  Pieter A Dijkmans; Paul Knaapen; Gertjan T J Sieswerda; Eric Aiazian; Cees A Visser; Adriaan A Lammertsma; Frans C Visser; Otto Kamp
Journal:  J Am Soc Echocardiogr       Date:  2006-03       Impact factor: 5.251

2.  Clinical analysis of myocardial perfusion and metabolism in patients with hypertrophic cardiomyopathy by single photon emission tomography and positron emission tomography.

Authors:  Y Ishida; S Nagata; T Uehara; Y Yasumura; K Fukuchi; K Miyatake
Journal:  J Cardiol       Date:  2001       Impact factor: 3.159

3.  Adenosine- and hypoxia-induced dilation of human coronary resistance arteries: evidence against the involvement of K(ATP) channels.

Authors:  Fiona M Lynch; Clare Austin; Anthony M Heagerty; Ashley S Izzard
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

4.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion.

Authors:  K Wei; A R Jayaweera; S Firoozan; A Linka; D M Skyba; S Kaul
Journal:  Circulation       Date:  1998-02-10       Impact factor: 29.690

5.  Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia.

Authors:  B Schwartzkopff; M Mundhenke; B E Strauer
Journal:  J Am Coll Cardiol       Date:  1998-04       Impact factor: 24.094

6.  Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation.

Authors:  R Krams; M J Kofflard; D J Duncker; C Von Birgelen; S Carlier; M Kliffen; F J ten Cate; P W Serruys
Journal:  Circulation       Date:  1998-01-27       Impact factor: 29.690

Review 7.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

8.  Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans.

Authors:  P Chareonthaitawee; P A Kaufmann; O Rimoldi; P G Camici
Journal:  Cardiovasc Res       Date:  2001-04       Impact factor: 10.787

9.  Myocardial microvascular abnormalities observed by intravenous myocardial contrast echocardiography in patients with hypertrophic cardiomyopathy.

Authors:  Katsuji Inoue; Mareomi Hamada; Tomoaki Ohtsuka; Yuji Hara; Yuji Shigematsu; Shigeru Nakata; Jitsuo Higaki
Journal:  Am J Cardiol       Date:  2004-07-01       Impact factor: 2.778

10.  Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Iacopo Olivotto; Franco Cecchi; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Francesca Girolami; Francesca Torricelli; Paolo G Camici
Journal:  J Am Coll Cardiol       Date:  2006-03-07       Impact factor: 24.094

View more
  7 in total

1.  Late gadolinium enhancement confined to the right ventricular insertion points in hypertrophic cardiomyopathy: an intermediate stage phenotype?

Authors:  Paco E Bravo; Hong-Chang Luo; Iraklis Pozios; Stefan L Zimmerman; Celia Pamela Corona-Villalobos; Lars Sorensen; Ihab R Kamel; David A Bluemke; Richard L Wahl; M Roselle Abraham; Theodore P Abraham
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-06-14       Impact factor: 6.875

2.  Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.

Authors:  Paco E Bravo; Stefan L Zimmerman; Hong-Chang Luo; Iraklis Pozios; Mahadevan Rajaram; Aurélio Pinheiro; Charles Steenbergen; Ihab R Kamel; Richard L Wahl; David A Bluemke; Frank M Bengel; M Roselle Abraham; Theodore P Abraham
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-15       Impact factor: 7.792

3.  Coronary microvascular disease in hypertrophic and infiltrative cardiomyopathies.

Authors:  Andreas A Giannopoulos; Ronny R Buechel; Philipp A Kaufmann
Journal:  J Nucl Cardiol       Date:  2022-08-01       Impact factor: 3.872

Review 4.  Assessment and Treatment for Coronary Microvascular Dysfunction by Contrast Enhanced Ultrasound.

Authors:  Junzhen Zhan; Longhe Zhong; Juefei Wu
Journal:  Front Cardiovasc Med       Date:  2022-06-20

5.  Long-term prognostic value of coronary flow velocity reserve in patients with hypertrophic cardiomyopathy: 9-year follow-up results from SZEGED study.

Authors:  Attila Nemes; Erika Balázs; Osama I I Soliman; Róbert Sepp; Miklós Csanády; Tamás Forster
Journal:  Heart Vessels       Date:  2009-09-27       Impact factor: 2.037

6.  Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy.

Authors:  Paola Roldan; Sriram Ravi; James Hodovan; J Todd Belcik; Stephen B Heitner; Ahmad Masri; Jonathan R Lindner
Journal:  Cardiovasc Ultrasound       Date:  2022-09-19       Impact factor: 2.263

7.  Aortic biomechanics in hypertrophic cardiomyopathy.

Authors:  Hala Mahfouz Badran; Ghada Soltan; Nagla Faheem; Mohamed Fahmy Elnoamany; Mohamed Tawfik; Magdi Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2015-07-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.